SPIEZIA, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.456
EU - Europa 1.163
AS - Asia 595
AF - Africa 14
OC - Oceania 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.435
CN - Cina 459
FI - Finlandia 299
IT - Italia 284
DE - Germania 178
SE - Svezia 150
VN - Vietnam 114
GB - Regno Unito 99
UA - Ucraina 64
IE - Irlanda 23
NL - Olanda 23
CA - Canada 15
FR - Francia 15
IN - India 15
EG - Egitto 10
AU - Australia 6
BR - Brasile 6
EU - Europa 5
AT - Austria 3
HN - Honduras 3
PL - Polonia 3
RO - Romania 3
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
GR - Grecia 2
JP - Giappone 2
KE - Kenya 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
RU - Federazione Russa 1
TR - Turchia 1
UG - Uganda 1
Totale 14.251
Salva come PNG Salva come JPEG
Città #
Fairfield 2.281
Woodbridge 1.234
Chandler 1.045
Houston 967
Ashburn 900
Ann Arbor 811
Seattle 767
Cambridge 742
Wilmington 712
Princeton 406
Medford 352
Des Moines 294
San Diego 287
Jacksonville 214
Helsinki 195
Beijing 164
Roxbury 149
Dong Ket 114
Padova 100
Boardman 81
Nanjing 65
New York 39
Hebei 29
London 27
Nanchang 25
Shenyang 25
Kharkiv 23
Norwalk 23
Dublin 20
Milan 20
Chicago 19
Los Angeles 19
Ogden 18
Jinan 17
Falls Church 16
Borås 12
Guangzhou 12
Kilburn 12
Redwood City 11
Tianjin 11
Jiaxing 10
Nürnberg 10
Redmond 10
Bologna 9
Mykolayiv 8
Chiswick 7
Hangzhou 7
Kingston 7
Palermo 7
Washington 7
Cagliari 6
Tappahannock 6
Trieste 6
Zhengzhou 6
Hefei 5
Kunming 5
Lappeenranta 5
Rockville 5
Rome 5
Shanghai 5
Acton 4
Alexandria 4
Dearborn 4
Dronten 4
Las Vegas 4
Nanning 4
Pune 4
Changsha 3
Detroit 3
Ferentino 3
Hounslow 3
Indiana 3
Prescot 3
Reggio Calabria 3
San Jose 3
Southwark 3
Sydney 3
São Paulo 3
Taiyuan 3
Tivoli 3
Wandsworth 3
Ansbach 2
Atlanta 2
Bassano Del Grappa 2
Bratislava 2
Bucharest 2
Cardano al Campo 2
Council Bluffs 2
Esslingen am Neckar 2
Falkenstein 2
Frankfurt am Main 2
Fremont 2
Groningen 2
Gurgaon 2
Istrana 2
Lanzhou 2
Limbiate 2
Marburg 2
Messina 2
Mestre 2
Totale 12.502
Salva come PNG Salva come JPEG
Nome #
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 182
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 167
Dynamics of circulating microparticles in obesity after weight loss 143
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 125
null 122
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 121
Acute oppressive chest pain in a 66-year-old woman with a recent Amplatzer device closure of patent foramen ovale 119
The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement 119
Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis 118
Microparticles as biomarkers of venous thromboembolic events 117
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 116
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 116
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 113
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 111
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 111
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 109
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 108
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 107
Short-term exposure to high levels of air pollution as a risk factor for acute isolated pulmonary embolism. 107
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 105
ABO blood group and the risk of post-thrombotic syndrome 105
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 105
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 105
Platelet factor V levels in moderate to severe congenital factor V deficiency. 103
Predictors of postoperative bleeding in children undergoing cardiopulmonary bypass: A preliminary Italian study 103
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 101
The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. 99
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 99
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 99
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 99
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 99
Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients 99
Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study 99
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 99
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 99
Effects of long-term administration of recombinant human protein C in xenografted primates. 98
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 97
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 95
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 94
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 94
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 94
Whole blood thromboelastometry profiles in women with preeclampsia 92
Plasma fibrinolytic capacity in renal transplant recipients: Effect of steroid-free immunosuppression therapy. 92
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 89
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 89
COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward 89
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 89
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 88
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 88
The current understanding of trauma-induced coagulopathy (TIC): a focused review on pathophysiology 88
Factor VIIa-antithrombin complexes in children with ischemic stroke. 86
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 86
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 86
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 84
Factor VIIa-AT complex plasma levels and arterial thrombosis. 84
On-treatment platelet reactivity in peripheral and coronary blood in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI) 84
The hazard of comparing apples and oranges: the proper indication for the use of recombinant activated clotting factor VII in cardiac surgery. 84
Idraparinux: review of its clinical efficacy and safety for prevention andtreatment of thromboembolic disorders. 83
Thrombophilia as a predictor of persistent residual vein thrombosis 83
Treatment of venous thromboembolism: the single-drug approach 83
More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia 83
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 82
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 82
Inherited thrombophilia and venous thromboembolism 80
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 80
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 80
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 79
Outcome of long-term prophylaxis after cerebral hemorrhage in a patient with severe hemophilia B. 79
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. 78
Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis. 78
The haemostatic system in acromegaly: a single-centre case–control study 78
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors 77
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 77
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 77
The diagnostic challenge: are we missing pulmonary embolism diagnosis in patients with syncope? 77
ABO blood groups and the risk of retinal vein occlusion 77
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 76
Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. 75
"Hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: Facts or technical artifacts? 75
Thrombophilia and the risk of post-thrombotic syndrome: Retrospective cohort observation 75
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. 75
Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation 74
The prognostic role of ThromboDynamic Index in patients with severe sepsis 74
Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation. 73
Freedom solo stentless aortic valve: quantitative and qualitative assessment of thrombocytopenia. 73
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure 73
Studio della sintesi del fattore V della coagulazione attraverso il modello sperimentale delle colture megacariocitarie ed il modello clinico delle famiglie con deficit ereditario di fattore V 73
Circulating microparticles in carriers of prothrombin G20210A mutation. 72
Cardiopulmonary bypass-induced coagulopathy in paediatric patients: the Role of Platelets in postoperative bleeding. A preliminary study 72
Whole blood rotation thrombelastometry in subjects undergoing vitamin K antagonist treatment: hypo- or hypercoagulable profiles? 71
Factor V Leiden paradox and the occurrence of distal vein thrombosis in a large cohort of thrombotic patients 71
Thrombophilia, risk factors and prevention 71
High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review 70
Prothrombin mutation conveying antithrombin resistance. 69
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. 69
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 69
Immobilization resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients 68
Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma 68
Role of factor v Leiden polymorphism or G20210A prothrombin variant in patients with sudden sensorineural hearing loss: A meta-analysis of the literature 68
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 68
Totale 9.154
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.442
article - articoli 48.340
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 64
Totale 107.846
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019957 0 0 0 0 0 0 0 0 0 191 437 329
2019/20202.389 304 103 20 183 255 164 244 301 347 239 119 110
2020/20212.664 76 158 163 187 241 92 103 259 248 251 189 697
2021/20223.917 94 808 325 264 146 219 111 416 150 108 274 1.002
2022/20232.335 666 228 50 256 328 264 6 137 240 24 112 24
2023/20241.002 50 175 147 138 85 170 80 54 38 65 0 0
Totale 14.642